MENACW 2023 Highlights Future Minerals Forum’s Crucial Role in Shaping Sustainable Mineral Value Chains for the Clean Energy Transition 17-10-2023, 23:44

Aberdeen International Announces Appointment of Martin 18-02-2023, 06:06

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical stage RXR agonist for treatment of normal aging-related neurodegeneration, at the FASEB Science Research Conference on Cellular and Molecular Mechanisms of Brai 18-09-2024, 22:07